Portola Pharmaceuticals, Inc.
PTLA
PTLA was delisted on the 1st of July, 2020.
171 hedge funds and large institutions have $2.11B invested in Portola Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 69 increasing their positions, 54 reducing their positions, and 10 closing their positions.
120% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 10
28% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 54
7% more funds holding
Funds holding: 160 → 171 (+11)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
4% less capital invested
Capital invested by funds: $2.2B → $2.11B (-$93.9M)
71% less call options, than puts
Call options by funds: $2.9M | Put options by funds: $10.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$30.8M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$29.8M |
| 3 |
Citigroup
New York
|
+$28.6M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$13.8M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$12.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$31.1M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$14.9M |
| 3 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$11.7M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$11.4M |
| 5 |
OTPPB
Ontario Teachers' Pension Plan Board
Toronto,
Ontario, Canada
|
-$9.25M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CSS
176
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$356K | -7,813 | Closed |
|
|
ICAS
177
Investors Capital Advisory Services
Lynnfield,
Massachusetts
| – | -$321K | -7,067 | Closed |
|
178
Simplex Trading
Chicago,
Illinois
| – | -$247K | -5,129 | Closed |
|
|
GCP
179
GSA Capital Partners
London,
United Kingdom
| – | -$223K | -4,900 | Closed |
|
|
SCA
180
Secor Capital Advisors
New York
| – | -$217K | -4,768 | Closed |
|
|
TRCT
181
Tower Research Capital (TRC)
New York
| – | -$52K | -1,140 | Closed |
|
PTLA Hedge Fund Activity: Q3 2015 in Review
171 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Portola Pharmaceuticals, Inc. (PTLA) for Q3 2015, worth a combined $2.11B — down 4.3% from $2.2B a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new PTLA positions and 10 closed out — a net gain of 12 holders — while 69 added to existing stakes and 54 trimmed.
The largest buyer was Millennium Management, adding an estimated $30.8M. The largest seller was Wellington Management Group, cutting an estimated $31.1M.
- 171 institutional investors held Portola Pharmaceuticals, Inc. (PTLA) as of Q3 2015, up from 160 in Q2 2015.
- Funds reported $2.11B of Portola Pharmaceuticals, Inc. stock for Q3 2015, down 4.3% quarter-over-quarter.
- 22 funds opened new Portola Pharmaceuticals, Inc. positions in Q3 2015 and 10 closed out, a net change of +12 holders.
- The largest Portola Pharmaceuticals, Inc. buyer in Q3 2015 was Millennium Management, an estimated $30.8M added.
- The largest Portola Pharmaceuticals, Inc. seller in Q3 2015 was Wellington Management Group, an estimated $31.1M sold.
Based on aggregated 13F filings for Q3 2015.